Can Tirzepatide Help You Lose Weight?
US$ 22.40
glp 1 agonist drug names America's Poison Centers The glucagon-like peptide 1 receptor
Description
[10] SURMOUNT-1 : Tirzepatide for the treatment of obesity produced ~2022% weight loss over 72 weeks, among the largest effects seen in pharmacologic obesity treatment
Akash, M
Rev Endocrine Metab Disord (2022) 23(3):52139
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
While side effects like nausea are common, theyre usually mild and temporary
Tirzepatide, a dual agonist of GIP and GLP-1 receptors, was approved for T2DM in 2022 and obesity/overweight in 2023 [33]
